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Eukaryotic membrane protein overproduction in
Lactococcus lactis
Edmund RS Kunji1, Ka Wai Chan1, Dirk Jan Slotboom1,2,
Suzanne Floyd3, Rosemary O’Connor3 and Magnus Monne´1Eukaryotic membrane proteins play many vital roles in the cell
and are important drug targets. Approximately 25% of all genes
identified in the genome are known to encode membrane
proteins, but the vast majority have no assigned function.
Although the generation of structures of soluble proteins has
entered the high-throughput stage, for eukaryotic membrane
proteins only a dozen high-resolution structures have been
obtained so far. One major bottleneck for the functional and
structural characterisation of membrane proteins is the
overproduction of biologically active material. Recent
advances in the development of the Lactococcus lactis
expression system have opened the way for the high-
throughput functional expression of eukaryotic membrane
proteins.
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Introduction
Membrane proteins fulfil many essential functions in the
eukaryotic cell. The flow of ions, nutrients and commu-
nication signals across the membrane is facilitated by ion
channels, transporters and receptors. Other membrane
proteins, such as photosystems, the complexes of the
respiratory chain and ATP synthase, are essential for
the conversion of energy. Large membrane protein com-
plexes such as the translocon, the nuclear pore and the
translocases of the inner and outer mitochondrial mem-
brane (TIM/TOM complexes) also play a key role, med-
iating the pathways for sorting, translocation and insertionCurrent Opinion in Biotechnology 2005, 16:546–551of proteins. Membrane proteins have been implicated in
many diseases, because they are positioned at the apex of
signalling pathways that regulate cellular processes. This
central role makes them a good target for drug treatment
and G-protein-coupled receptors (GPCRs), ion channels
and neurotransmitter transporters currently constitute
more than 40% of all established drug targets [1].
Genome sequencingprojects have identifiedvast numbers
of novel open reading frames that contain predicted trans-
membrane segments. The division of these unknown
membrane proteins into families is relatively straightfor-
ward, but the assignment of function is not because the
structural basis of ligand or substrate recognition is often
unknown. If one considers polypeptide chains with less
than 90% sequence identity, there are 50 times more
known structures of soluble proteins than membrane
proteins (Figure 1). Structures of eubacterial membrane
proteins constitute 80% of the entries and were obtained
frommaterial that was either naturally abundant or homo-
logously expressed. The structures of only 17 eukaryotic
integral membrane proteins have been determined. In 16
of these cases, the protein under study was purified from
abundant natural sources (http://blanco.biomol.uci.edu/
Membrane_Proteins_xtal.html). The only exception is
the crystal structure of the rat voltage-dependent shaker
family potassium channel, which was obtained using pro-
tein expressed in Pichia pastoris (see Update).
To increase our knowledge of the function and structure
of eukaryotic membrane proteins, novel approaches for
their over-production need to be developed. This review
provides a short description of the published expression
strategies and goes on to discuss the recently developed
Lactococcus lactis expression system.
Eukaryotic expression systems
The advantages of eukaryotic hosts for the expression of
eukaryotic membrane proteins are clear. The systems for
translation, targeting, insertion and post-translational
modifications are compatible, thus the proteins are likely
to be well-folded and active. Microbial hosts like Sacchar-
omyces cerevisiae, Schizosaccharomyces pombe or Pichia pas-
toris have the added advantage of being cheap and easy to
culture in large amounts. Among the disadvantages of
these systems are the differences in post-translational
modifications and the potential proteolysis of the target
protein by endogenous proteases. Heterologous expres-
sion has been improved by taking advantage of yeastwww.sciencedirect.com
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Figure 1
Numbers of high-resolution structures of soluble proteins and membrane proteins. (a) The total number of polypeptide structures with less than
90% sequence identity for soluble proteins (diagonal stripes) and membrane proteins (horizontal stripes) deposited in the Protein Data Bank (PDB)
by August 2005. The number of PDB entries of (b) archeal, (c) eubacterial and (d) eukaryotic integral membrane proteins divided into three
categories indicating the source of the material used for the crystallization trials: naturally abundant (Nat, white), homologously expressed
(Hom, black) and heterologously expressed (Het, grey).physiology, such as tuning of the expression levels to
avoid the unfolded protein response (a signaling mechan-
ism triggered by the stress of protein expression) [2]. It is
also possible to tailor metabolism so that the survival of
the host is dependent on the functional expression of the
protein [3,4]. Modification of the expressed protein
through the use of fusion partners can also be advanta-
geous; for example, C-terminal fusion proteins have been
used to stabilize the expression of GPCRs, whereas the
addition of N-terminal signal peptides can improve tar-
geting and insertion [5–7].
Insect cell expression systems have been used for the
successful overproduction of functional GPCRs under the
control of baculovirus promoters [8] or endogenous pro-
moters in transgenic insects [9]. Using these systems post-
translational acylation of the receptors, which is important
for their regulation, is achieved, but compatible N-gly-
cosylation is not [10]. GPCRs, ion channels and transpor-
ters have been functionally expressed in mammalian cell
lines that have compatible systems for post-translational
modifications, targeting, insertion and folding [11,12,13];
however, these systems are technically challenging and
relatively expensive.
Bacterial expression systems
Bacterial expression systems are convenient and rela-
tively cheap. However, potential difficulties arise fromwww.sciencedirect.comdifferences in membrane protein biogenesis, such as the
transcription and translation machinery, membrane com-
position, and the targeting, insertion and folding path-
ways [14]. The inability of bacterial expression systems
to introduce post-translational modifications, such as gly-
cosylation, could affect function, although this can also be
an advantage for crystallization trials.
The Gram-negative bacterium Escherichia coli has been
the main host for the production of soluble proteins and
prokaryotic membrane proteins. High-level expression of
functional eukaryotic membrane proteins has also been
achieved in E. coli, but in most cases problems such as
low-level expression, toxicity and inclusion body forma-
tion tend to occur. These problems can be overcome to
some extent by changing media components, carbon
source or the growth temperature [15]. The selection
of strains with improved production properties [16] or
the use of strains in which proteases have been deleted
has also been successful [15]. Likewise, construct-opti-
misation— through the use of different promoters, fusion
partners [17–19], truncations and the addition of N-term-
inal signal peptides — has proved beneficial [20]. Meth-
ods for the high-throughput screening of endogenous
membrane protein overexpression have been developed,
but have not been applied to eukaryotic membrane
protein production in E. coli [21,22]. In another approach,
the archaebacteriumHalobacterium salinariumwas used toCurrent Opinion in Biotechnology 2005, 16:546–551
548 Biochemical engineeringexpress eukaryotic membrane proteins as fusion partners
of bacterio-opsin [23].
The lactococcal expression system
The use of the Gram-positive bacterium L. lactis as an
expression system has great potential for the overproduc-
tion of membrane proteins and has been used successfully
for the homologous overexpression of transporters from
the major facilitator superfamily, ABC transporters,
mechanosensitive channels and peptide transporters
[24] Heterologous expression of eukaryotic membrane
proteins in L. lactiswas first demonstrated with the human
KDEL receptor, the hydrogenosomal ADP/ATP carrier
and yeast mitochondrial carriers, which were all expressed
in a functional form and at high levels [24]. A human
ABC transporter has also been overproduced in a func-
tional form in this host [25].
Several properties of L. lactis make it ideal for the over-
production of membrane proteins for functional and struc-
tural studies, as discussedbelow.The lactic acidbacterium
grows to high cell densities (about 1 h doubling time)
without the need for aeration, and its single membrane
simplifies membrane protein targeting, insertion and cell
fractionation. The nisin-inducible expression system [26]
was developed in this host and offers a strong and tightly
regulated promoter system that allows highly reproducible
expression even when the proteins are toxic to the cell
[24]. In all reported caseswhereL. lactishas beenused for
expression, a specific transport or binding activity of the
protein was observed, demonstrating that the system is
reliable and reproducible for the production of functional
material. Activities could be determined even when the
expressed protein was barely detectable by western blot-
ting. Furthermore, the expressed proteinswere only found
in themembrane and not in inclusion bodies, whichmeant
that their activities could be established without the need
for purification, refolding and reconstitution. This impor-
tant property enables functional characterisation in whole
cells, because substrates, ligands or inhibitors can pass
through the cell wall to interact directly with the mem-
brane protein. Studies to identify the transporter sub-
strates and receptor ligands are facilitated because L.
lactis usually lacks endogenous proteins with the same
function. So far, significant degradation of isolated mem-
brane proteins has not been observed, because the bacter-
ium has a relativelymild proteolytic capability. Of note for
structural studies, the availability of multiple amino acid
auxotrophic strains of L. lactis has facilitated the incorpora-
tion of selenomethionine for the phasing of X-ray diffrac-
tion data and for the specific labelling of proteins forNMR.
Taken together, these properties clearly highlight the
importance of L. lactis as a suitable host for the over-
expression of membrane proteins.
Recently, we have employed this system for the expres-
sion and functional characterisation of members of theCurrent Opinion in Biotechnology 2005, 16:546–551mitochondrial carrier family, which are found exclusively
in eukaryotes [24]. Mitochondrial carriers carry meta-
bolites and cofactors through the mitochondrial inner
membrane and have a unique biogenesis pathway (see
[27,28] for recent reviews). When the carriers are over-
expressed inE. coli, they are produced in inclusion bodies
from which they can be purified, refolded and reconsti-
tuted, but the efficiency is low [28–30]. When mitochon-
drial carriers are expressed in yeast, degradation is
observed during the isolation of mitochondria using
standard procedures. Clearly both these hosts have dis-
advantages, but mitochondrial carriers have been over-
expressed successfully in L. lactis in the cytoplasmic
membrane. The observed expression levels are sufficient
to enable crystallisation trials to be performed for struc-
tural studies [24]. Transport assays can be carried out in
whole cells if sufficient amounts of exchangeable sub-
strate are present in the cytosol. Alternatively, it is
possible to isolate lactococcal membranes by mechanical
disruption and differential centrifugation, to fuse them to
liposomes by freeze-thawing and extrusion, and to load
them with cold substrate before carrying out the transport
assay.
Expression trials have revealed possible limitations of the
expression system. The yeast ADP/ATP carrier AAC2 is
expressed poorly, whereas another isoform, AAC3, is
expressed well, even though they share 87% identity
(ERS Kunji et al. unpublished). The only major differ-
ence between the two proteins is in the N-terminal region
preceding the first transmembrane a-helix. Inhibitor stu-
dies have shown that AAC3 is expressed in the lactococcal
membrane with its N and C terminus to the outside of the
cell [24] in accordance with the ‘positive inside rule’
[31]. The requirement to translocate the N terminus to
the outside of the cell could have been a limitation in the
insertion of the carrier. An N terminus-out topology is a
potential impediment in expression, as polytopic mem-
brane proteins in bacteria usually have a cytoplasmic
location for both the N and C termini (57%) [32]. This
problem could be resolved by modifying the N terminus
or through the introduction of a signal peptide for the
translocation of the N-terminal region to the outside of
the cell (Figure 2), as has been done in other expression
systems [5–7,20]. Another potential limitation of the
lactococcal expression system is the AT-rich codon usage
of the organism (65%). Codon optimisation may be a
general necessity to improve the expression of mamma-
lian proteins in this organism [33]. Green fluorescent
protein (GFP) has been used successfully in E. coli as a
quantifiable marker for the overexpression of endogenous
membrane proteins [21] and for the localisation of the C
terminus in a high-throughput fashion [32]. Recently, the
functional expression of the human KDEL receptor in L.
lactis was improved more than ten times by using a GFP
fusion to the C terminus (Figure 3) [34]. The successful
use of GFP opens possibilities for the convenient detec-www.sciencedirect.com
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Figure 2
Schematic representations of the yeast mitochondrial ADP/ATP carrier AAC2 as (a) wild-type protein, (b) with an AAC3 N-terminal replacement,
(c) as an N-terminal truncation or (d) as a signal peptide fusion.
Figure 3
Functional overexpression of the human KDEL receptor as a wild-type protein and as a C-terminal GFP fusion protein. The numbers show the
specific binding of the ligand [3H]-YTSEHDEL to (a) isolated membranes of the control strain, (b) the strain expressing the wild-type KDEL
receptor, and (c) the strain expressing the KDEL receptor–GFP fusion. (Data taken from [34].)
www.sciencedirect.com Current Opinion in Biotechnology 2005, 16:546–551
550 Biochemical engineeringtion of membrane proteins in high-throughput expression
studies.
Recently, the L. lactis expression systemwas used success-
fully to identify a novel adenine nucleotide transporter
from the mitosome of Entamoeba histolytica [35]. The
substrate specificity, as well as the driving forces for trans-
port, was determined in lactococcal membranes that con-
tained the overexpressed transporter without the need for
further purification. These results suggest that this expres-
sion system has great potential for the systematic assign-
ment of protein function in high-throughput applications.
Conclusions
The expression studies described here prove the concept
of using L. lactis for the overproduction of eukaryotic
membrane proteins for functional and structural analysis.
The expression system has many practical advantages,
but it is also clear that difficult topologies and codon usage
might limit expression. These problems can be resolved
through optimisation of the expression constructs, show-
ing that there is scope for further improvement of the
system.
Although the lactococcal expression system has only been
tried with a limited set of membrane proteins, there is no
reason to assume that these approaches cannot be applied
to other important eukaryotic membrane proteins. High-
throughput protocols for the identification of orphan
membrane proteins and structural genomics are currently
being developed.
Update
The paper by Long, Campbell and Mackinnon presents
the first structure of a eukaryotic integral membrane
protein that was obtained by heterologous overexpression
[36]. The procedures for the expression of the voltage-
dependent K+ channel in P. pastoris were developed by
Parcej and Eckhardt-Strelau [37].
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